1. Feldman, Mark et. al.

, 2010, Sleisenger & Fordtrans Gastrointestinal and

Liver Disease : Pathophysiology / Diagnosis / Management, edisi 9,

Philadelphia : Saunders.
2. Glickmean RM. Penyakit Radang Usus (Kolitis Ulseratif dan Penyakit

Crohn). Dalam: Asdie AH, editor. Harrison Prinsip-Prinsip Ilmu Penyakit

Dalam. Volume 4. Edisi Ke-13. Jakarta: Penerbit Ilmu Kedokteran EGC;

2000.
3. Djojoningrat D. Inflammatory Bowel Disease: Alur Diagnosis Dan

Pengbatannya di Indonesia. Dalam: Sudoyo AW dkk, wditor. Buku Ajar

Ilmu Penyakit Dalam. Jilid 1. Edisi ke-4. Jakarta: Pusat Penerbitan

Departemen Ilmu Penyakit Dalam FKUI; 2006.

4. CCFA (Crohns and Colitis Foundation of America). What Is Crohns

Disease?. Available at URL : http://www.ccfa.org/what-are-crohns-and-

colitis/what-is-crohns-disease/ .accessed : 15 April 2017.

5. Snell, Richard S. 2006. Anatomi Klinik Untuk mahasiswa Kedokteran.

Jakarta: EGC.
6. Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease:

an overview. Surg Clin North Am. Jun 2007.

7. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et

al. Association of NOD2 (CARD 15) genotype with clinical course of

Crohn's disease: a cohort study. Lancet. May 11 2002.

8. Ghazi, L.J. Katz, J. Anand,B.S Balasundaram, P. Coash, M.L. Nachimutu,

S. Qureshi, W.A. Rangasamy, P. Raynor, K.M. Talavera F. George, Y.W.

2013. Crohn Disease. Medscape Reference. 25 March 2013.

9. Wilkins T, Jarvis K, Patel J. Diagnosis and management of Crohn's

disease. Am Fam Physician. Dec 15 2011.

10. Duerr RH. Update on the genetics of inflammatory bowel disease. J Clin

Gastroenterol. Nov-Dec 2003.

11. Kidd R, Mezwa DG, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, et al.

Imaging recommendations for patients with newly suspected Crohn's

disease, and in patients with known Crohn's disease and acute

exacerbation or suspected complications. American College of Radiology.

ACR Appropriateness Criteria. Radiology. Jun 2000.

12. Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, et al.

ASGE guideline: endoscopy in the diagnosis and treatment of

inflammatory bowel disease. Gastrointest Endosc. Apr 2006.

13. Robinson M. Optimizing therapy for inflammatory bowel disease. Am J

Gastroenterol. Dec 1997.

14. Lim WC, Hanauer S. Aminosalicylates for induction of remission or

response in Crohn's disease. Cochrane Database Syst Rev. Dec 8 2010.

15. Peyrin-Biroulet L, Laclotte C, Bigard MA. Adalimumab maintenance

therapy for Crohn's disease with intolerance or lost response to infliximab:

an open-label study. Aliment Pharmacol Ther. Mar 15 2007.

16. Ford AC, Bernstein CN, Khan KJ, Abreu MT, Marshall JK, Talley NJ, et

al. Glucocorticosteroid therapy in inflammatory bowel disease: systematic

review and meta-analysis. Am J Gastroenterol. Apr 2011.

17. Turner D, Grossman AB, Rosh J, et al. Methotrexate following

unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J

Gastroenterol. Dec 2007.

18. Mcdonald, JWD, Tsoulis DJ, Macdonald JK and Feagan BG. Methotrexate

for Induction of Remission Refractory Crohns Disease. Cochrane

Database of Systematic Reviews. Published by JohnWiley & Sons, Ltd. 27

June 2012.
19. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W. American

Gastroenterological Association Institute medical position statement on

corticosteroids, immunomodulators, and infliximab in inflammatory bowel

disease. Gastroenterology. Mar 2006.

20. DHaens G, Panaccione R, Higgins P, et al. The London Position

Statement of the World Congress of Gastroenterology on Biological

Therapy for IBD with the European Crohns and Colitis Organization:

When to start, when to stop, which drug to choose, and how to predict

response? Am J Gastroenterol. 2011.

21. Pans J, Bouzas R, Chaparro M, Garca-Snchez V, Gisbert JP, Martnez

de Guereu B, et al. Systematic review: the use of ultrasonography,

computed tomography and magnetic resonance imaging for the diagnosis,

assessment of activity and abdominal complications of Crohn's disease.

Aliment Pharmacol Ther. Jul 2011.

22. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance

IC, et al. Natalizumab induction and maintenance therapy for Crohn's

disease. N Engl J Med. Nov 3 2005.

23.
ASCRS (The American Society of Colon and Rectal Surgeons) ; Strong

SA, Koltun WA, Hyman NH, Buie WD, for the Standards Practice Task

Force Practice parameters for the surgical management of Crohns disease.

Dis Colon Rectum. 2007.

24. Cima RR, Pemberton JH. Ileostomy, colostomy, and pouches. In: Feldman

M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's

 Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders

Elsevier; 2010.
25. Jobanputra, S. and Weiss, E.G. Strictureplasty. Clin Colon Rectal Surg.

New York, USA. 2007.

26. Ajlouni, Y. Iser, J.H and Gibson, P.R. Endoscopic balloon dilatation of

intestinal strictures in Crohns Disease : safe alternative to surgery. J

Gastroenterol Hepatol. Melbourne, Australia. 2007 Apr; 22.

27. Sjamsuhidajat, R. dan de Jong, Wim. 2003. Buku Ajar Ilmu Bedah. Ed.2.

Jakarta : EGC.
28. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk

and mortality in patients with Crohn's disease. Gastroenterology. Dec

2003.